Literature DB >> 2987368

Systemic lymphoid atrophy in coxsackievirus B3-infected mice: effects of virus and immunopotentiating agents.

D Matteucci, A Toniolo, P G Conaldi, F Basolo, Z Gori, M Bendinelli.   

Abstract

Adult mice infected with coxsackievirus B3 (CB3) showed a generalized lymphoid involution. This effect was produced by most of the isolates and clones of CB3 and, to a lesser extent, by coxsackievirus B1 but not by other highly pathogenic picornaviruses. While moderate involution of the thymus also occurred in mild CB3 infections, peripheral changes strictly correlated with the severity of disease. The major alteration of the thymus was a massive cortical depletion, whereas the reduction of spleen and lymph node cellularity appeared devoid of selectivity. No histological and ultrastructural signs of CB3 replication in such organs could be detected. Attempts to demonstrate CB3 replication in thymus, spleen, and lymph node cells were unsuccessful. CB3-induced lymphoid atrophy was not prevented by adrenalectomy and was exacerbated by three different immunopotentiating agents. Thus, certain picornaviruses may cause severe stress-independent lymphoid damage in the absence of viral replication in situ. A role for autoreactive mechanisms is suggested.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2987368     DOI: 10.1093/infdis/151.6.1100

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  9 in total

1.  Persistent infection of human pancreatic islets by coxsackievirus B is associated with alpha interferon synthesis in beta cells.

Authors:  W Chehadeh; J Kerr-Conte; F Pattou; G Alm; J Lefebvre; P Wattré; D Hober
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

2.  Interferons mediate terminal differentiation of human cortical thymic epithelial cells.

Authors:  Pierre-Olivier Vidalain; David Laine; Yona Zaffran; Olga Azocar; Christine Servet-Delprat; T Fabian Wild; Chantal Rabourdin-Combe; Hélène Valentin
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

3.  Group B coxsackieviruses readily establish persistent infections in human lymphoid cell lines.

Authors:  D Matteucci; M Paglianti; A M Giangregorio; M R Capobianchi; F Dianzani; M Bendinelli
Journal:  J Virol       Date:  1985-11       Impact factor: 5.103

4.  Distinct pathogenic effects of group B coxsackieviruses on human glomerular and tubular kidney cells.

Authors:  P G Conaldi; L Biancone; A Bottelli; A De Martino; G Camussi; A Toniolo
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

5.  Direct interactions of coxsackievirus B3 with immune cells in the splenic compartment of mice susceptible or resistant to myocarditis.

Authors:  D R Anderson; J E Wilson; C M Carthy; D Yang; R Kandolf; B M McManus
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

6.  Autoimmunity in Coxsackievirus B3 induced myocarditis: role of estrogen in suppressing autoimmunity.

Authors: 
Journal:  Future Virol       Date:  2010-05-01       Impact factor: 1.831

7.  Acanthamoeba castellanii promotion of in vitro survival and transmission of coxsackie b3 viruses.

Authors:  A Mattana; C Serra; E Mariotti; G Delogu; P L Fiori; P Cappuccinelli
Journal:  Eukaryot Cell       Date:  2006-04

8.  Pathogenesis of murine enterovirus myocarditis: virus dissemination and immune cell targets.

Authors:  K Klingel; S Stephan; M Sauter; R Zell; B M McManus; B Bültmann; R Kandolf
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

9.  Mesenchymal stem cells and inflammatory cardiomyopathy: cardiac homing and beyond.

Authors:  S Van Linthout; Ch Stamm; H-P Schultheiss; C Tschöpe
Journal:  Cardiol Res Pract       Date:  2011-03-06       Impact factor: 1.866

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.